Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00248404
Status:
COMPLETED
Last Update Posted:
2022-05-16
First Post:
2005-11-03
Brief Title:
NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase TS
Sponsor:
Kiadis Pharma
Organization:
Kiadis Pharma
Organization Data
Organization:
Kiadis Pharma
Class:
INDUSTRY
Study ID:
CR-TSC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kiadis Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None